RxDoctor Payments Data

Laura Lowry, PA

Physician Assistant · Fullerton, CANPI 1841408390

Payments from drug & device makers

$2,300in general payments, 2019–2025

Across 122 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$545
  • Boehringer Ingelheim$329
  • Novartis$309
  • Amgen$238
  • Sanofi-aventis U.S. LLC$183
  • E.r. Squibb & Sons, L.L.C.$119
  • plus $577 from 14 others

What the payments were for

  • Food & beverage$2,300100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,300 in reported general payments places this provider in the 80th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$65,588
Medicare patients
370
Services billed
801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban258$223,596
XareltoRivaroxaban68$60,031
EntrestoSacubitril/Valsartan39$31,896
Repatha SureclickEvolocumab27$23,157
FarxigaDapagliflozin Propanediol16$9,379
Ranolazine ErRanolazine24$2,641
Metoprolol Succinate210$2,539
Nitroglycerin128$1,978
Potassium Chloride104$1,615
Carvedilol192$1,265
Losartan Potassium117$1,148
Amlodipine Besylate344$1,127
Midodrine Hcl21$959
Rosuvastatin Calcium68$824
Metoprolol Tartrate107$788

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$545$223,596258 claims
Johnson & JohnsonXarelto$78$60,03168 claims
NovartisEntresto$309$31,89639 claims
AstraZenecaFarxiga$37$9,37916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Fullerton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →